Skip to main content
. Author manuscript; available in PMC: 2014 Aug 18.
Published in final edited form as: J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):387–392. doi: 10.1097/QAI.0b013e31828ff979

Table 3.

Number and percent of subjects with evidence of primary ARV resistance, by donor demographics, HIV risk factors, donation characteristics, and genotypes.

Total N(%) of
resistance
Likelihood ration
Chi-Square p-value
Total 303 36 (11.9)
Site
  Recife 98 8 (8.2) 0.21
  Belo Horizonte 47 6 (12.8)
  Sao Paulo 62 12 (19.4)
  Rio de Janeiro 96 10 (10.4)
Donation Type
  Community 185 24 (13.0) 0.64
  Replacement 96 9 (9.4)
  Other 22 3 (13.6)
Gender
  Male 251 30 (12.0) 0.93
  Female 52 6 (11.5)
Age
  <30 144 20 (13.9) 0.30
  ≥30 159 16 (10.1)
Sexual Orientation
  Straight/Heterosexual/Refused/DK 188 19 (10.1) 0.30
  Bisexual 53 6 (11.3)
  Gay/Homosexual 62 11 (17.7)
IVDU of Sex Partner of IVDU
  Yes 25 4 (16.0) 0.52
  No 278 32 (11.5)
Sex with HIV+ Partner
  Yes 40 8 (20.0) 0.11
  No 263 28 (10.7)
MSM/Sex Partner of MSM
  Yes 129 18 (14.0) 0.34
  No 174 18 (10.3)
Infection Status
  Recent 39 6 (15.4) 0.24
  Long term 202 18 (8.9)
Genotype
  B 230 31 (13.5) 0.11
  Non B 73 5 (6.9)